Anke van den Berg
prof. dr.
I work as a clinical molecular biologist in the department of Pathology. In this function I supervise and implement advanced molecular diagnostic techniques. Within my research line, I focus on the molecular pathogenesis of B-cell Hodgkin and non-Hodgkin lymphoma. The specific fields of interest are genomic aberrations, genetic susceptibility, and the role of small and long noncoding RNAs. I have several international collaborations and am PI and co-PI in various projects.
Additional file 4: of Targeted sequencing of circulating cell-free DNA in stage II-III resectable oesophageal squamous cell carcinoma patients
Access to document
10.6084/m9.figshare.9697766.v1
Details of all somatic mutations. Coding sequence mutations, amino acid changes, CADD score, ALT read counts and MAF for tumour, pre-surgery plasma, post-surgery plasma, and WBC are listed. (XLSX 42 kb)
Pei Meng (Shantou University Medical College) (Contributor)Jiacong Wei (Shantou University Medical College) (Contributor)Yiqun Geng (Contributor)Shaobin Chen (Contributor)Miente Martijn Terpstra (Contributor)Qiongyi Huang (Contributor)Qian Zhang (Contributor)Zuoqing Su (Contributor)Wanchun Yu (Contributor)Min Su (Contributor)Klaas Kok (Contributor)Anke van den Berg (Contributor)Jiang Gu (Contributor)
Additional file 2: of Targeted sequencing of circulating cell-free DNA in stage II-III resectable oesophageal squamous cell carcinoma patients
Access to document
10.6084/m9.figshare.9697754.v1
Clinical and pathological features of ESCC patients. (XLSX 10 kb)
Pei Meng (Shantou University Medical College) (Contributor)Jiacong Wei (Shantou University Medical College) (Contributor)Yiqun Geng (Contributor)Shaobin Chen (Contributor)Miente Martijn Terpstra (Contributor)Qiongyi Huang (Contributor)Qian Zhang (Contributor)Zuoqing Su (Contributor)Wanchun Yu (Contributor)Min Su (Contributor)Klaas Kok (Contributor)Anke van den Berg (Contributor)Jiang Gu (Contributor)
Additional file 1: of Targeted sequencing of circulating cell-free DNA in stage II-III resectable oesophageal squamous cell carcinoma patients
Access to document
10.6084/m9.figshare.9697751.v1
Overview of the 483 genes present in the Illumina cancer gene panel. (XLSX 14 kb)
Pei Meng (Shantou University Medical College) (Contributor)Jiacong Wei (Shantou University Medical College) (Contributor)Yiqun Geng (Contributor)Shaobin Chen (Contributor)Miente Martijn Terpstra (Contributor)Qiongyi Huang (Contributor)Qian Zhang (Contributor)Zuoqing Su (Contributor)Wanchun Yu (Contributor)Min Su (Contributor)Klaas Kok (Contributor)Anke van den Berg (Contributor)Jiang Gu (Contributor)
Additional file 3: of Targeted sequencing of circulating cell-free DNA in stage II-III resectable oesophageal squamous cell carcinoma patients
Access to document
10.6084/m9.figshare.9697760.v1
Overview of the sequencing results. In this table, paired read number, Q30, aligned read number, percentage of duplicate reads, aligned unique read number and mean target coverage are listed per sample. (XLSX 18 kb)
Pei Meng (Shantou University Medical College) (Contributor)Jiacong Wei (Shantou University Medical College) (Contributor)Yiqun Geng (Contributor)Shaobin Chen (Contributor)Miente Martijn Terpstra (Contributor)Qiongyi Huang (Contributor)Qian Zhang (Contributor)Zuoqing Su (Contributor)Wanchun Yu (Contributor)Min Su (Contributor)Klaas Kok (Contributor)Anke van den Berg (Contributor)Jiang Gu (Contributor)
Additional file 5: of Targeted sequencing of circulating cell-free DNA in stage II-III resectable oesophageal squamous cell carcinoma patients
Access to document
10.6084/m9.figshare.9697778.v1
Overview of the pathway analysis by DAVID. All genes with predictive pathogenic mutation were analysed through DAVID. The table shows the KEGG pathways, genes in each pathway and p-values. (XLSX 14 kb)
Pei Meng (Contributor)Jiacong Wei (Contributor)Yiqun Geng (Contributor)Shaobin Chen (Contributor)Martijn Terpstra (Contributor)Qiongyi Huang (Contributor)Qian Zhang (Contributor)Zuoqing Su (Contributor)Wanchun Yu (Contributor)Min Su (Contributor)Klaas Kok (Contributor)Anke van den Berg (Contributor)Jiang Gu (Contributor)